LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p/TET1 axis

Table 2 Correlations between LINC01089 expression and clinical characteristics in GC patients

Pathological indicators	Number of patients	Relative expression of LINC01089		P value
Pathological indicators	Number of patients	High expression	Low expression	P value
All cases	87	41	46
Age (years)
< 57	48	22	26	0.789
≥ 57	39	19	20	0.789
Gender
Female	32	13	19	0.354
Male	55	28	27	0.354
Tumor size (cm)
< 5	46	27	19	0.022*
≥ 5	41	14	27	0.022*
T stage
1–2	48	28	20	0.020*
3–4	39	13	26	0.020*
Lymphatic metastasis
Positive	20	5	15	0.024*
Negative	67	36	31	0.024*
Histologic differentiation
Well/moderately	57	26	31	0.667
Poor	30	15	15	0.667

ISSN: 1475-2867